FCCC LOGO Faculty Publications
Langer CJ
Osteonecrosis of the jaw, a recently recognized sequela of bisphosphonate therapy: case report
Support Cancer Ther. 2006 Jan 1;3(2) :122-4
PMID: 18632450   
Back to previous list
Abstract
In the oncologic setting, osteonecrosis, which generally occurs after a temporary or permanent loss of blood supply to the bones, is frequently caused by radiation or combined chemoradiation therapy, particularly in head and neck cancers. However, this well-recognized phenomenon remains relatively rare. Recently, cases of osteonecrosis of the jaw have been reported over a 2-year period, with the majority occuring in oncology patients, the only commonality being the use of bisphosphonate therapy. Herein, we report a patient with breast carcinoma metastatic to bone that developed osteonecrosis that ultimately resolved with supportive measures. She was successfully rechallenged with bisphosphates without recurrence or sequelae.
Notes
Langer, Corey J United States Supportive cancer therapy Support Cancer Ther. 2006 Jan 1;3(2):122-4.